Hot melt extrusion as a strategy to improve formononetin bioavailability and enable hydrogel formulation
Planta Medica · 01.03.2026 · 92 (03) · 414-415
DOI: 10.1055/s-0045-1815445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A Gościniak und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Formononetin, an isoflavonoid compound, exhibits agonistic activity towards estrogen receptors, thereby modulating nuclear signaling pathways involved in the production of structural proteins such as elastin and collagen [ 1 ]. However, its therapeutic application is limited by its low aqueous solubility, which significantly reduces its bioavailability. Improving the solubility of formononetin may enable the development of an effective hydrogel formulation with regenerative and moisturizing properties. The aim of this study was to obtain a system with improved solubility of formononetin by combining it with hydroxypropyl-β-cyclodextrin (HPβCD) and Kollidon ® VA 64 using a hot melt extrusion (HME) process, and to evaluate its potential for hydrogel-based delivery. The extrudate was characterized using thermogravimetric analysis (TG), differential scanning calorimetry (DSC), and X-ray powder diffraction (XRPD), confirming the formation of an amorphous dispersion of formononetin. The obtained HME system was then incorporated into a hydrogel formulation composed of gelatine, carboxymethylcellulose (CMC), arabic gum, and glycerine. The final hydrogel was evaluated in terms of formononetin release kinetics (using Franz diffusion cells), mechanical strength, and swelling capacity. The formulation demonstrated suitable mechanical properties, improved release and solubility of formononetin, and favorable water absorption. The application of HME with HPβCD and Kollidon ® VA 64 enabled a significant increase in formononetin solubility and the development of a stable hydrogel formulation with potential for skin therapy and regeneration. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Gościniak, A., Trzaskoma, P., & Cielecka-Piontek, J. (2026). Hot melt extrusion as a strategy to improve formononetin bioavailability and enable hydrogel formulation. Planta Medica, 92(03), 414-415. https://doi.org/10.1055/s-0045-1815445
Vancouver
Gościniak A, Trzaskoma P, Cielecka-Piontek J. Hot melt extrusion as a strategy to improve formononetin bioavailability and enable hydrogel formulation. Planta Medica. 2026;92(03):414-415. doi:10.1055/s-0045-1815445
BibTeX
@article{Gociniak2026,
author = {Gościniak, A and Trzaskoma, P and Cielecka-Piontek, J},
title = {Hot melt extrusion as a strategy to improve formononetin bioavailability and enable hydrogel formulation},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {414--415},
doi = {10.1055/s-0045-1815445}
}
EUVIMED